与癌症相关的纤维细胞:最近的进展和治疗影响
Christina Paraskeva1, Athanasia Stavropoulou2, Vasiliki Koliaraki1
1Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece.
Current opinion in cell biology
|December 2, 2025
概括
在瘤微环境 (TME) 中,与癌症相关的纤维细胞 (CAF) 呈现出显著的异质性. 了解CAF亚种群是开发针对结构复杂性和耐药性的新型癌症疗法的关键.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微环境 (TME) 对癌症的进展至关重要.
- 与癌症相关的纤维细胞 (CAF) 是丰富且具有影响力的 stromal 细胞.
- CAF的功能异质性影响瘤的发病,转移和治疗抵抗.
研究的目的:
- 审查目前对CAF生物学和异质性的理解.
- 为突出CAF空间组织,动态和免疫功能的最新发现.
- 讨论针对CAF亚群的新兴治疗策略.
主要方法:
- 文献综述综合了最近的进展.
- 单细胞测序和空间转录组学数据的整合.
- 关于CAF在癌症中的作用的机制研究.
主要成果:
- CAFs表现出显著的功能异质性,具有不同的子群体.
- CAF亚种群在瘤促进,免疫调节和治疗耐药性方面具有特殊作用.
- 最近的进展揭示了CAF的空间组织和时间动态.
结论:
- 了解CAF异质性对于癌症治疗至关重要.
- 针对特定的CAF亚群提供了新的治疗机会.
- 开发有效的癌症疗法需要考虑肌肉复杂性和CAF介导的耐药性.
更多相关视频
相关概念视频
Introduction to Fibroblasts
3.8K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.8K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K


